The model predicts that highly antigenic tumors that elicit a perforin-based response from CTLs respond to ICI (Figure 2A) unless constitutively active FGFR3 signaling greatly accelerates tumor cells cycling (Figure 5). The gene discussed is PRF1; the disease is neoplasm.